Working… Menu

Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 (ASPEN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04655586
Recruitment Status : Recruiting
First Posted : December 7, 2020
Last Update Posted : October 6, 2021
Colorado Prevention Center
Information provided by (Responsible Party):
ARCA Biopharma, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 30, 2021
Estimated Study Completion Date : December 31, 2021